← Companies|Hetero Drugs
He

Hetero Drugs

Hyderabad INFounded 199325,000 employees
Private CappharmaPrivateInfectious DiseaseOncology
Platform: API ARV
Market Cap
N/A
All Drugs
2
Clinical Trials
2
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
HET-1500HET-1500Phase 2/31RadioligandTauFGFRiPBC
HET-7567HET-7567Phase 21Gene TherapyTYK2CD3xCD20RSVRB
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (2)
2026-08-03
HET-7567 Ph2 Data
SLE
Ph2 Data
2030-10-15
HET-1500 Ph3 Readout
PBC
Ph3 Readout